Cough, Cold and Allergy (Hay Fever) Remedies in Taiwan, China

November 2026

Cough, cold and allergy (hay fever) remedies in Taiwan, China demonstrates robust growth in 2026, which is notably resilient given prevailing inflation and demographic decline. The environment remains highly attractive, underpinned by strong consumer trust in licensed pharmacies, high levels of brand loyalty, and a regulatory framework that limits online competition and favours established players. However, success increasingly hinges on strategic pricing, supply chain adaptability, compliance with tightening regulation, and product differentiation, especially as rising living costs and population decline are shifting purchasing behaviour towards targeted, value-driven solutions and smaller pack sizes. To outperform, brands must prioritise channel partnerships, invest in pharmacist engagement, and maintain clear safety messaging, while simultaneously managing costs and innovating to meet evolving consumer preferences in both product formulation and presentation.

USD 1,195
Request More Information

Delivery:

Files are delivered directly into your account soon after payment is received and any tax is certification is verified (where applicable).

This report comes in PDF with additional info in Excel included.

Overview:

Understand the latest market trends and future growth opportunities for the Cough, Cold and Allergy (Hay Fever) Remedies industry in Taiwan with research from Euromonitor International's team of in-country analysts – experts by industry and geographic specialisation.

Key trends are clearly and succinctly summarised alongside the most current research data available. Understand and assess competitive threats and plan corporate strategy with our qualitative analysis, insight and confident growth projections.

If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in Taiwan, our research will help you to make informed, intelligent decisions; to recognise and profit from opportunity, or to offer resilience amidst market uncertainty.

The Cough, Cold and Allergy (Hay Fever) Remedies in Taiwan report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volume and value sizes, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent research methodology, conducted in-country

This report answers:

  • What is the market size of Cough, Cold and Allergy (Hay Fever) Remedies in Taiwan?
  • Which are the leading brands in Cough, Cold and Allergy (Hay Fever) Remedies in Taiwan?
  • How are products distributed in Cough, Cold and Allergy (Hay Fever) Remedies in Taiwan?
  • How has the regulatory and operating environment for Cough, Cold and Allergy (Hay Fever) Remedies changed in Taiwan?
  • How are considerations such as stress, self-medication and shifting consumer lifestyles shaping demand for Cough, Cold and Allergy (Hay Fever) Remedies
  • How significant are wider health concerns and consumer awareness in determining sales?
  • Where is future growth expected to be most dynamic?

Key Data Insights

Key Industry Trends

Inflationary pricing and tariff shocks push cough, cold and allergy remedies towards growth
Combination remedies maintain value leadership as medicated confectionery accelerates
Regulatory tightening and counterfeit risks reshape consumer trust and brand strategy
Chart 1 Value Sales 2021-2031
Chart 2 Value Sales by Category 2026
Pharmacy chains set to strengthen ties with leading brands to secure shelf space
Combination remedies will consolidate leadership as medicated confectionery accelerates
Clear labelling and safety claims to drive purchase decisions amid rising cost pressures
Chart 1 Forecast Value Sales 2021-2031
Chart 2 Forecast Value Sales by Category 2026-2031
Established brands maintain stable shares as NHI delisting reinforce pharmacy-led purchasing
Hi-Clearance's acquisition of Astar Chemical strengthens domestic production
Chart 1 Company Shares 2026
Chart 2 Brand Shares 2026
Pharmacies consolidate distribution lead as regulatory barriers persist
Retail e-commerce faces structural limitations amid consumer demand for trust
Chart 1 Retail Channels 2021-2026
Taisho and JPmed use pricing adjustments and private label launches to adapt to inflationary pressure
Pabron restrictions and counterfeit interception use regulatory tightening to shift demand
Hi-Clearance uses Astar acquisition to secure domestic supply resilience and reduce import reliance
Chart 1 Real GDP Growth 2021-2031
Chart 2 Inflation 2021-2031
Chart 1 Population 2021-2031
Chart 2 Population by Generation 2026
Chart 3 Consumer Expenditure 2021-2031

Country Reports Disclaimer

The following categories and subcategories are included:

Cough, Cold and Allergy (Hay Fever) Remedies

  • Antihistamines/Allergy Remedies (Systemic)
    • Paediatric Allergy Remedies
    • Paediatric Cough/Cold Remedies
  • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
  • Cough Remedies
    • Nasal Sprays
    • Oral Decongestants
    • Inhalant Decongestants
    • Decongestant Rubs
    • Nasal Decongestant Drops
    • Nasal Decongestant Plasters
  • Medicated Confectionery
  • Pharyngeal Preparations

Cough, Cold and Allergy (Hay Fever) Remedies

This is the aggregation of decongestants, cough remedies, pharyngeal preparations, medicated confectionery, combination products, antihistamines and paediatric cough, cold and allergy remedies.

See all of our definitions
Share:

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This report originates from Passport, our Cough, Cold and Allergy (Hay Fever) Remedies research and analysis database.

NEW REPORT GUARANTEE

If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!